Trinity Biotech (TRIB)

[HeilHiden]

It’s a value stock is why I’m in

[StockLogistics]

Six month consolidation ends today, should have news soon therefore imo

[StockLogistics]

There is a gap at .68 cents and I think the market is spooked by the possibility of increased tax selling because of the laws being passed in Congress, this company could provide a PR, last one was 10/18/21

[HeilHiden]

Let’s rolllll

[HeilHiden]

$100,000 order at $2.00

[HeilHiden]

It’s very undervalued and it’s time will come. Probably when the EPS shows a profit for a year. Or if they brought back the dividend.

[StockLogistics]

Two and half months I tried to provide my opinion on this stock,
The numbers were great, but the market disagrees about the future, all it did was decrease in this time frame, they have to put news out, the matrix angle to this ended up being nucypher and keep crypto mooning, not trinity, all imo.

[HeilHiden]

$TRIB’s African HIV testing will also be coming back as pandemic ends adding to the profits!

[HeilHiden]

How about the profit last quarter?

[StockLogistics]

Could see a bit of a downturn here without something substantial from the company monday, chart not looking good, on the last leg of the Eiffel Tower to the down side to retest .62 all time low possible, I think people are expecting the pandemic to end soon, all imo

[StockLogistics]

Reminds me of RAP# which traded in the $17 area and then moved to $40 in one day

RAP#

Share Structure

Market Cap Market Cap
876,099,384
10/12/2021
Authorized Shares
Not Available
Outstanding Shares
29,488,367
08/06/2021
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
No Par Value

TRIB

Share Structure

Market Cap Market Cap
12,541,022
08/20/2021
Authorized Shares
Not Available
Outstanding Shares
20,901,703
12/31/2019
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
No Par Value

[StockLogistics]

10:13a ET 10/8/2021 - Benzinga
Trinity Biotech Subsidiary Biopool U.S. Wins Defense Logistic Agency Contract Worth Up To $4M

https://dibbs2.bsm.dla.mil/Downloads/Awards/07OCT21/SPE2DE22D0001.PDF

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Investors like additional Revenue streams imo

[HeilHiden]

Agreed!

[oilin07]

EXTREMELY UNDERVALUED

[HeilHiden]

20 cent EPS. This is a monster awakening!

[HeilHiden]

Financials are coming out today!

[HeilHiden]

Just made a community on Reddit go check it out!

[HeilHiden]

$TRIB is trading at half its revenues! Value play here!

[StockLogistics]

“4:30p ET 8/31/2021 - Globe Newswire
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results
Mentioned: TRIB
Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2021 on Thursday, September 9, 2021. The Company has scheduled a conference call for that same day, Thursday September 9, 2021 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

US Toll Free: 1-844-861-5499International Toll: 1-412-317-6581Ireland Toll: 014311269Ireland Toll Free: 1800932830
Please ask to be joined into the Trinity Biotech call.

A simultaneous webcast of the call can be accessed at:

https://services.choruscall.com/mediaframe/webcast.html?webcastid=VuKATKEQ

A replay of the call can be accessed until September 16, 2021 by dialing:

US Toll Free: 1-877-344-7529International Toll: 1-412-317-0088Replay Code: 10159977
To access the replay using an international dial-in number, please see the link below:

https://services.choruscall.com/ccforms/replay.html

A webcast of the call will be available for 30 days at: https://services.choruscall.com/mediaframe/webcast.html?webcastid=VuKATKEQ

Replays will be available 1 hour after the end of the conference.

(Company's website: www.trinitybiotech.com.)”

[StockLogistics]

Trinity did well last fall and winter

[StockLogistics]

Big opportunity as flu season approaches for trinity, earnings posted within a few days. All imo.

[StockLogistics]

Looking good today as traders continue to take medical positions ahead of September/winter imo

[StockLogistics]

Still holding its own impressively during periods of downward momentum Imo

[StockLogistics]

Still strong today, could see major increase in this quality company all imo

[StockLogistics]

Looking good again this morning imo

[StockLogistics]

Share Structure

Market Cap Market Cap
12,541,022
08/20/2021
Authorized Shares
Not Available
Outstanding Shares
20,901,703
12/31/2019
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
No Par Value

SEC Filings
FORM TYPE RECEIVED PERIOD END DATE
6-K 07/19/2021 07/19/2021
6-K 05/27/2021 05/27/2021
20-F 04/30/2021 12/31/2020
6-K 03/30/2021 03/30/2021
6-K 03/26/2021 03/26/2021
SC 13G/A 02/16/2021
S-8 02/12/2021
SC 13G/A 02/12/2021
SC 13G 02/10/2021
6-K 01/05/2021 01/05/2021

BUSINESS DESCRIPTION
Not available
TRINITY BIOTECH PLC
IDA Business Park
Bray
Co. Wicklow
Ireland
353 1276 9800
FINANCIAL REPORTING
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
12/31/2020
CIK
0000888721
Fiscal Year End
12/31
COMPANY OFFICERS & CONTACTS
Ronan O'Caoimh
CEO
Rory Nealon
CFO
BOARD OF DIRECTORS
Not available
OTHER COMPANY INSIDERS
Not available
SERVICE PROVIDERS
Not available
PROFILE DATA
SIC - Industry Classification
2835 - Diagnostic substances
Incorporation Information
IRL

https://www.otcmarkets.com/stock/TRIB/security

[StockLogistics]

Trinity increasing as winter approaches imo:

[StockLogistics]

Great medical stock for fall and winter imo

[StockLogistics]

Major player in the industry here imo

2:53p ET 7/16/2021 - Dow Jones
Trinity Biotech Up After Update on Covid-, HIV-Testing Products
Mentioned: TRIB

By Michael Dabaie

Trinity Biotech American depositary receipts were up 8%, to $2.21, after the company issued an update on its testing-products pipeline.

The company earlier said it wouldn't devote additional investment to the UniGold SARS-CoV-2 rapid antibody test and instead focus resources on a Covid-19 antigen test, for which it expects a larger market.

Trinity said that in June it made an emergency use authorization application to the FDA for the UniGold antibody test. The FDA later informed the company that given the volume of EUA requests, it isn't prioritizing this type of test for review, Trinity said.

Due to the adoption of Covid-19 vaccines and the focus on using evidence of vaccination rather than presence of antibodies as proof of immunity, the company said it "now expects that the use for such tests will be limited and thus the potential revenues from the sales of this product to be minimal."

Trinity said it is at an advanced stage in the development of a SARS-CoV-2 antigen test. The test can be run without any specialised equipment, provides a result in 12 minutes and utilises an anterior nasal swab sample.

As the pandemic and responses have developed, antigen tests have continued to play an important role in the overall diagnostic response, the company said.

"Even as the roll out of vaccines continues, the role of antigen tests in providing assurance around active infection remains important and Trinity Biotech expects antigen testing to have a continuing place in the overall public health response to Covid-19, even as vaccinations continue," Trinity said.

Trinity also said it developed a new product, TrinScreen HIV, specifically for the screening market. The company said it has been the main confirmatory test provider for the detection of the HIV virus in Africa for years.

The company said it is preparing for the automated manufacture of TrinScreen HIV at its facility in Ireland in anticipation of World Health Organization approval.

Write to Michael Dabaie at [e-mail]

(END) Dow Jones Newswires

July 16, 2021 14:53 ET (18:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.

[oilin07]

Not sure. All I know is that from a valuation standpoint this should be closer to $10. Trinscreen WHO approval will send this flying. Anything else Covid related is a bonus.

[Raptor17]

oilin, any thoughts on todays move? Just a delay to the results?

[oilin07]

Looks like going to take longer

[oilin07]

I predict $10+ within a month

[oilin07]

Looks like we bottomed imo

[oilin07]

Could possibly test mid $5s before $7+

[wesley_]

$6.19 nice

[oilin07]

Looking good....

[oilin07]

Let's break and hold $3

[oilin07]

Strong

[oilin07]

Strong buy

[oilin07]

Predicting $5.00+ by end of October. Let's see what happens

[whytestocks]

NEWS: $TRIB Trinity Biotech Announces Results for Q2, 2020

DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020. Quarter 2 Results &#x...

In case you are interested TRIB - Trinity Biotech Announces Results for Q2, 2020

[realfast95]

this second test, 12 minutes on a drop of blood is faster than $OPGN
but being in development is not good enough

The first test doesn't say how long it takes to get results

[realfast95]

Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test
August 20 2020 - 10:31AM


Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets announced that it has filed its submission for an Emergency Use Authorization (EUA) for its Covid-19 IgG ELISA antibody test with the FDA. This test will determine which individuals within the population have been exposed to the SARS-CoV-2 virus. The transfer of production to our facility in Jamestown, New York is complete, our manufacturing capability is very significant and the instrumentation platforms that perform ELISA testing are available in virtually every testing laboratory in the world.

The product demonstrates specificity in excess of 98% and sensitivity in excess of 95%, in samples of 14 days or more from symptom onset. EUA submission allows us to begin marketing the product immediately.

In addition, the Company is developing a rapid point-of-care Covid-19 test to detect antibodies to the virus that can be run in 12 minutes using one drop of blood procured by finger prick. This test will have utility similar to that outlined above for the ELISA antibody test. Once development and transfer to manufacturing of this rapid test is complete we intend to avail of the FDA’s EUA pathway to expedite its approval for sale in the USA.

This pipeline of Covid-19 products complements our existing Viral Transport Media (VTM) product, which is used in the Covid-19 sample collection process for PCR molecular testing. We have scaled up the manufacture of VTM to meet increased levels of demand over the past months and we expect demand to continue as Covid-19 testing remains critical to the management of the pandemic.

Ronan O’Caoimh, Chief Executive Offer commented “We are very pleased to announce the submission of our Covid-19 ELISA antibody test for FDA Emergency Use Authorization (EUA). The test demonstrates both impressive specificity and sensitivity. Meanwhile, the ELISA testing platform with its excellent reputation for quality and widespread adoption makes it an ideal format for large scale antibody testing.”

[realfast95]

Forks, who needs some forks?

[TFMG]

$TRIB | #TrinityBiotech In Strong Uptrend



Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

[oilin07]

This looks ready to pop. We could see $10+

[peterus]

most people dont know TRIB makes his own antibodytest
$$$$$$

[peterus]

$$$

[whytestocks]

News: $TRIB What Are The Best Penny Stocks To Trade? 3 Moving In July 2020

3 Penny Stocks To Trade Or Fade Right Now Love them or hate them, penny stocks are red hot right now. The cheap shares of small companies are attracting major interest from retail traders in 2020. Whether you’ve just started trading or you’re a seasoned vet, you’ve proba...

Got this from TRIB - What Are The Best Penny Stocks To Trade? 3 Moving In July 2020